The 12th Annual Conference on Cryobiomedicine and Devices was held in Jinan on October 17
On the morning of October 17, 2020, the 12th National Annual Conference on Low Temperature Biomedicine and Instruments was held in Jinan, Spring City, with the theme of "Cryogenic Helping Health China" as the theme for two days. More than 100 cryogenic biomedical experts from all over the country attended the meeting.
Wang Chao, Secretary-General of the Specialized Committee on Low Temperature Biomedical of Small Refrigerating Machines of the Chinese Association of Refrigeration, Liu Baolin, Dean of School of Medical Devices and Foods of Shanghai University of Technology, Deputy Director of Modern Minimally Invasive Medical Devices and Technical Engineering Research Center of the Ministry of Education, Deputy Director of China Refrigerating Association, Head of Biobiology Branch of Bio-Sample Bank of China Association of Medicine and Biotechnology, Bi Yanwen, Director of Cardiovascular Surgery, Qilu Hospital of Shandong University, Chairman of Shandong Society of Cold Medicine, Deputy Director of Laboratory Management Division of China Center for Disease Control and Prevention. Wei Qiang, director of national pathogenic microorganism resource bank, etc., was invited to attend the meeting.
Wang Baoqing, President of Yinfeng Bioengineering Group Co., Ltd., Chu Zhonghua, Director of Shandong Umbilical Cord Blood Hematopoietic Stem Cell Bank, Jia Chunsheng, General Manager of Yinfeng Cold Medicine Technology Co., Ltd., Tang Qiuan, General Manager of Sichuan Haishengjie Low Temperature Technology Co., Ltd. and Cheng Jinsheng, General Manager of Shanghai Dongfulong Medical Equipment Co., Ltd., were invited to attend the meeting.
At the opening ceremony, Professor Liu Baolin opened the conference and welcomed and thanked the participants in his speech. At the same time, he pointed out that cryogenic biomedicine, as a new cross-discipline gradually formed in recent decades, integrates life science, modern medicine and cryogenic technology, and carries out cryogenic treatment, resuscitation, repair and treatment to human cells, tissues, organs and even the whole human body, which is one of the most rapidly developing subjects in the field of life sciences in recent years. Relying on the joint efforts of modern cryomedical experts, the development and market scale of cryogenic biomedical industry in China are already at the advanced level in the world.
In his speech, Bi Yanwen said that cryogenic biomedical is very important, although it is a small subject. Clinically, many work cannot be carried out without the support of cryogenic biomedical support, such as heart transplantation, cryopreservation of heart valve and other organs, low temperature for the life of the window. He called for a closer combination of low temperature and medicine so that cryogenic technology can truly serve clinical and patient services and better help healthy China.
In his speech, President Wang Baoqing stressed that cryogenic biomedicine is a new cross discipline. Yinfeng Biological Group attaches great importance to the development of cryogenic biomedicine, continuously devotes itself to the exploration of the mechanism of cryopreservation of life resources and the development and application of leading-edge technologies, takes the lead in initiating cryogenic research focusing on the preservation, transportation and clinical application of human tissues and organs, and completed the first case of cryopreservation in Asia in 2017. At the same time, Yinfeng Biological Group aims at the frontier of biomedical science and technology in the world, and is also committed to technology research and development, medical transformation and clinical research in human cell, tissue and organ storage, gene sequencing technology, cell technology, cryomedical technology and other biomedical fields.
In his speech, Secretary General Wang Chao said that the proposal and construction of health China strategy brought new opportunities for biotherapy, biological sample bank, cryopreservation of cell tissue, stem cell bank and the development of cryobiomedicine. Through organizing various academic seminars and new technology exhibitions, organizing review and recommending excellent papers of refrigeration society and scientific and technological awards of refrigeration society, China Refrigeration Society has vigorously promoted the cooperation between low-temperature medicine production and research, so that new technologies can be better applied to practice and serve the society.
At the end of the opening ceremony, the experts at the conference made thematic reports on the significance of cryopreservation, key problems in preservation technology, cryogenic biomedical materials and human genetic resources preservation, etc., sharing research results, analyzing bottleneck shortboards and exploring technical difficulties. For experts unable to reach the conference site due to special reasons, organize video connection and conduct online lectures. During the meeting, participants asked questions and in-depth exchanges on the topics involved in the report.
After the meeting, the guests will visit and exchange at Yinfeng Institute of Life Sciences.
The meeting was sponsored by the Low Temperature Biology Group of Biobiology Branch organized by China Association of Refrigeration and Biotechnology Association of China, undertaken by Yinfeng Low Temperature Medical Technology Co., Ltd. and co-sponsored by Shanghai Low Temperature Biomedical Technology Service Platform, Haier Biomedical Co., Ltd., Shanghai Dongfulong Medical Equipment Co., Ltd., Shandong Yinfeng Life Science Research Institute and Shandong Yinfeng Life Science Public Welfare Foundation.
We expect that, under the common drive of national experts in hypothermia and the common concern of people from all walks of life, hypothermia medicine will become hot gradually and get more and more attention.